Highlights and Developments at Hi-Q Marine Biotech

Advancing Innovation and Community at Hi-Q Marine Biotech

#

At Hi-Q Marine Biotech, we are dedicated to fostering innovation, supporting our community, and advancing scientific research. Below, we present a curated selection of our latest news and milestones, reflecting our ongoing commitment to excellence and social responsibility.

Recent News and Achievements

#

Empowering Future Leaders with Kindness and Integrity : Hi-Q Scholarship Awards Dr. Chen Wei-Hua, Brand Ambassador of Hi-Q ONCOFUCO, Receives the 28th Fervent Global Love of Lives Award, Featured in Multiple Media Outlets Hi-Q's ONCOFUCO® and BALANGLUCO® Products Receive SNQ Certification New Research Publication: OliFuco® Oligo Fucoidan Attenuates Cardiac Remodeling by Inhibiting Galectin-3 Secretion, Fibrosis, and Inflammation in a Mouse Model of Pressure Overload Hi-Q ONCOFUCO Dominates Taiwan's Fucoidan Industry Supporting Pink Ribbon Month with the Taiwan Breast Cancer Foundation 2024 Agricultural Value-Added Processing Industry Forum Hi-Q Proudly Supports the 1919 After-School Tutoring for Disadvantaged Children New Research Publication: OliFuco® Oligo Fucoidan as an Adjunct Therapy for Lung Cancer The New Launch of COSMOS Approved FucoSkin® CS Hi-Q’s Ocean Challenge: Strengthening Body and Protecting Seas through Open Water Swimming Explore Our Latest Interview with Fortune Magazine/Voices of Leaders

Key Highlights

#

• Empowering Future Leaders: On June 10th, Hi-Q hosted a scholarship ceremony at the Hi-Q Brand House, recognizing students from National Taiwan Ocean University (NTOU) for their academic dedication and commitment to service.

• Celebrating Resilience and Advocacy: Dr. Wei-Hua Chen, a 70-year-old cardiologist and director of Hongxin Clinic, received the 28th Fervent Global Love of Lives Award for his remarkable journey overcoming four types of cancer and his contributions to patient care and rural medicine.

• Product Excellence Recognized: Hi-Q’s flagship products, ONCOFUCO® and BALANGLUCO®, achieved SNQ certification for 2025, underscoring our commitment to quality and safety.

• Scientific Breakthroughs: Research led by Dr. Wen-Rui Hao demonstrated that OliFuco® Oligo Fucoidan can attenuate cardiac remodeling by inhibiting galectin-3 secretion, fibrosis, and inflammation, with findings published in the journal Biomedicines.

• Market Leadership: ONCOFUCO Oligo Fucoidan has become the leading brand in Taiwan’s fucoidan market, holding the top position in both brand recognition and market share, and earning 20 international certifications.

• Community Engagement: Hi-Q actively supports initiatives such as the Taiwan Breast Cancer Foundation’s Pink Ribbon Month and the 1919 After-School Tutoring for Disadvantaged Children, reflecting our dedication to social responsibility.

• Sustainable Innovation: The launch of FucoSkin® CS, certified by Ecocert as COSMOS Approved, highlights our focus on sustainable beauty and green chemistry.

• Promoting Health and Wellness: Hi-Q’s leadership participated in an open water swimming event in Green Island, demonstrating the importance of a healthy lifestyle and environmental stewardship.

• Industry Collaboration: Hi-Q was honored to participate in the 2024 Agricultural Value-Added Processing Industry Forum, hosted by the Ministry of Agriculture at National Taiwan University.

• Thought Leadership: Our recent interview with Fortune Magazine/Voices of Leaders discusses Hi-Q’s pivotal role in bridging the cancer care gap through innovative supplementary health products.

For more details on each story, please visit the respective news articles linked above.